Lazard Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
|
|||||
2021
Q3 | $65K | Buy |
|
|||||
2020
Q4 | – | Sell |
|
|||||
2020
Q3 | $45K | Sell |
|
|||||
2020
Q2 | $59K | Buy |
|
|||||
2020
Q1 | $51K | Buy |
|
|||||
2019
Q4 | $46K | Buy |
|
|||||
2019
Q3 | $10K | Buy |
|
|||||
2018
Q2 | – | Sell |
|
|||||
2018
Q1 | $1.54M | Buy |
|
|||||
2017
Q4 | $708K | Buy |
|
|||||
2015
Q1 | – | Sell |
|
|||||
2014
Q4 | $4.76M | Buy |
|
|||||
2014
Q3 | $221K | Buy |
|